MICRO-X LIMITED — Capital/Financing Update 2021

Feb 11, 2021

==> picture [159 x 46] intentionally omitted <==

Micro-X Limited, ABN 21 153 273 735

SHARE PURCHASE PLAN - UPDATE

Adelaide, Australia, 12 February 2021: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode x-ray technology for the healthcare and security markets globally, advises that that the offer under the Share Purchase Plan ( SPP ) opened on 4 February 2021 when SPP offer booklets were despatched to eligible shareholders by Computershare.

Micro-X has been contacted by some shareholders who have experienced delays in receiving their SPP offer booklet in the mail. For any eligible shareholder who may not have received their SPP offer booklet, they may:

• Telephone : phone the Offer Information Line on 1300 850 505 (within Australia) or +61 3 9415 4000 (outside Australia) between 8.00 am and 4.30pm (Adelaide time) on Monday to Friday during the SPP Offer period; or

• Online : Access your personalised Application Form which accompanied the SPP booklet at www.investorcentre.com by logging in with your SRN/HIN.

The SPP offer is scheduled to close on 17 February 2021, unless closed earlier by the Company.

This announcement is approved by Kingsley Hall, Company Secretary of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited (the Company ) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has two mobile digital medical x-ray systems being sold commercially for diagnostic healthcare applications and Micro-X medical products are now in operation in 14 countries around the world.

Micro-X has a portfolio of innovative products in development, including the MBI for imaging Improvised Explosive Devices in security, defence and counter-terrorism applications; a next-generation self-service X-Ray Airport Checkpoint Portal with an integrated body scanner; and a lightweight brain CT imager for early stroke diagnosis in ambulances. Micro-X has its core R&D, engineering and production capability in Adelaide, Australia with a fully in-sourced CNT tube manufacturing line and approximately 95% Australian locally manufactured content.

CONTACTS

Micro-X Limited	Investor Enquiries
Peter Rowland Managing Director Tel: +61 8 7099 3966 E:admin@micro-x.com	David Allen / John Granger Hawkesbury Partners Tel: +61 2 9103 9494 E:dallen@hawkesburypartners.com jgranger@hawkesburypartners.com

Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042, AUSTRALIA Legal/74788397_2

www.micro-x.com